Macrocytosis as a potential parameter associated with survival after tyrosine kinase inhibitor treatment. [electronic resource]
Producer: 20160712Description: 101-106 p. digitalISSN:- 1879-0852
- Antineoplastic Agents -- adverse effects
- Carcinoma, Renal Cell -- blood
- Disease-Free Survival
- Erythrocyte Indices
- Erythrocytes -- drug effects
- Female
- Hemoglobins -- metabolism
- Humans
- Indoles -- adverse effects
- Kidney Neoplasms -- blood
- Male
- Molecular Targeted Therapy
- Predictive Value of Tests
- Proportional Hazards Models
- Protein Kinase Inhibitors -- adverse effects
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Pyrroles -- adverse effects
- Retrospective Studies
- Risk Factors
- Sunitinib
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.